Related Experiment Video
Updated: Oct 1, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Chronic Disease Management Service Opportunities for Community Pharmacists During the COVID-19 Pandemic
Gregory Dwyer1,2, Adebola Popoola3, Naomi Seiler1
1George Washington University School of Public Health, Washington, DC.
Abstract:
Health system disruption caused by the COVID-19 pandemic prompted public health professionals to reevaluate potential barriers and opportunities to community pharmacist provision of chronic disease management services and to identify opportunities for maximizing community pharmacists' impact. Researchers conducted semistructured interviews with representatives from chronic disease prevention and pharmacy practice and policy organizations to identify key themes across multiple interviews and novel responses of interest. Interviewees described a lack of payment models to support pharmacist-provided chronic disease management services but noted opportunities for community pharmacists to demonstrate their value in offering services they are uniquely positioned to provide and to implement better workflow solutions. Successfully demonstrating pharmacists' value and making the case for reimbursement from payors, as well as optimizing pharmacy workflow, are critical to maximizing pharmacists' impact in chronic disease prevention and management.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Chronic Kidney Disease IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
COPD: Management Using Bronchodilators and Corticosteroids

